Top hedge fund manager David Neuhauser says the world is in a “boomer renaissance” and investors must be betting big on certain sectors that play the theme. The world is aging rapidly, and sectors equivalent to tourism, health care and biotech will profit from that, in accordance with Neuhauser, who’s founder and chief investment officer of Livermore Partners. Investors should give attention to areas which can be “tailored to wealthy boomers” who need to spend on their lifestyles and on improving their health and well-being, he said, adding that examples include weight reduction drugs and traveling and cruises. “They’re the one demographic which owns probably the most assets (homes, stocks, bonds, etc) with low fixed rate mortgages,” Neuhauser said. “Plenty of those individuals even have money, they usually have money in the cash market accounts, in order that they have a superb income stream as well and that helps support their lifestyle,” he told CNBC’s ” Street Signs Asia ” last week. Big Pharma particularly has “a whole lot of money resulting from these aging boomers,” Neuhauser said. He said large pharmaceutical corporations may now acquire biotech firms if solid initial results are produced, as a substitute of waiting for the completion of late-stage trials. This, he said, could end in more acquisitions. He told CNBC Pro, “I feel the world is on this boomer renaissance now and there are some stocks which can be seeing great moves.” He added that the stocks “should not mega tech which shows you other areas tied to the wealth [effect] are helping broadening out gains.” Below are the stocks he named and the buy rankings and average upside given by analysts covering them, in accordance with FactSet.
A key step forward for Novo Nordisk’s GLP-1 pill
Novo Nordisk flags flutter outside their office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, July 14, 2025. Tom Little...
